K191993

Substantially Equivalent

Yumizen C1200 CRP

Applicant: HORIBA ABX SAS
Product code: DCK
Advisory panel: Immunology
Date received: 2019-07-25
Decision date: 2019-10-03
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Montpellier Cedex 4, FR

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.